Company intelligence / Profile preview

Jord BioScience

St. Paul, Minnesota, United Statesjordbioscience.com ↗

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

Jord BioScience has demonstrated significant improvements in field trials by enhancing the efficacy of existing commercial microbial products for plant growth, disease resistance, and nutrient uptake. Their technology has shown up to 135% improvement in biofungicide performance and substantial increases in biomass and nutrient solubilization. Multiple rounds of field tests are ongoing with major agribusiness partners; full commercialization is projected within a few years.

Therapeutic areas: OtherMetabolic DisordersInfectious Diseases
Modalities: Microbial therapyLive biotherapeutic product therapy
Industry: Agriculture & AgTech

Partnerships

Corteva AgriscienceBASFSyngentaBayer

Beyond the preview

Go deeper on Jord BioScience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jord BioScience.

Explore the full profile